Disclosing Genetic Risk of Alzheimer’s Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II)
Author(s) -
Emily A. Largent,
Twisha Bhardwaj,
Maramawit Abera,
Shana D. Stites,
Kristin Harkins,
Alan J. Lerner,
Angela R. Bradbury,
Jason Karlawish
Publication year - 2021
Publication title -
journal of alzheimer s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-210675
Subject(s) - apolipoprotein e , disease , psychology , perception , alzheimer's disease , stigma (botany) , clinical psychology , gerontology , medicine , psychiatry , pathology , neuroscience
Current practice guidelines recommend against Apolipoprotein E (APOE) testing. However, advances in Alzheimer's disease (AD) research and care may soon change this.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom